Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma
- Conditions
- Multiple Myeloma
- Registration Number
- NCT06659276
- Brief Summary
The primary objective is to evaluate the concordance of FDG PET/CT and total body DWI MRI sequences performed during staging and at the completion of therapy. Specifically, we will assess the positivity rates, both patient-based and lesion-based (total and by district), of the two methods during staging and at the completion of therapy. An interim analysis will be conducted comparing the two methods, followed by a final prognostic analysis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 83
-
• Patients with symptomatic myeloma in the staging phase or with suspected symptomatic myeloma in the diagnostic phase
- Patients who have signed the informed consent form
-
Patients simultaneously affected by other neoplastic diseases or with a history of other neoplasms in the previous 5 years
- Age < 18 years
- Women who are breastfeeding or pregnant
- Patients with metal implants or devices that constitute an absolute contraindication for MRI
- Patients with severe claustrophobia
- Patients with bone pain that prevents prolonged maintenance of the supine position
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method positivity rate 33 months comparison per patient and per lesion between FDG PET CT and WB DWI
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Policlinico S.Orsola Malpighi
🇮🇹Bologna, Italy